154 related articles for article (PubMed ID: 23211026)
41. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
Hu Z; Li S; Medeiros LJ; Sun T
Hum Pathol; 2017 Jul; 65():175-179. PubMed ID: 28232160
[TBL] [Abstract][Full Text] [Related]
42. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
[TBL] [Abstract][Full Text] [Related]
43. T-cell chronic lymphocytic leukemia or small-cell variant of T-cell prolymphocytic leukemia: a historical perspective and search for consensus.
Rashidi A; Fisher SI
Eur J Haematol; 2015 Sep; 95(3):199-210. PubMed ID: 25846234
[TBL] [Abstract][Full Text] [Related]
44. Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia.
Heinonen K; Mahlamäki E; Hämäläinen E; Nousiainen T; Mononen I
Cancer Genet Cytogenet; 1994 Nov; 78(1):28-35. PubMed ID: 7987802
[TBL] [Abstract][Full Text] [Related]
45. A gene on chromosome Xq28 associated with T-cell prolymphocytic leukemia in two patients with ataxia telangiectasia.
Thick J; Mak YF; Metcalfe J; Beatty D; Taylor AM
Leukemia; 1994 Apr; 8(4):564-73. PubMed ID: 8152252
[TBL] [Abstract][Full Text] [Related]
46. Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci.
Gesk S; Martín-Subero JI; Harder L; Luhmann B; Schlegelberger B; Calasanz MJ; Grote W; Siebert R
Leukemia; 2003 Apr; 17(4):738-45. PubMed ID: 12682631
[TBL] [Abstract][Full Text] [Related]
47. Unusual breakpoint distribution of 8p abnormalities in T-prolymphocytic leukemia: a study with YACS mapping to 8p11-p12.
Sorour A; Brito-Babapulle V; Smedley D; Yuille M; Catovsky D
Cancer Genet Cytogenet; 2000 Sep; 121(2):128-32. PubMed ID: 11063795
[TBL] [Abstract][Full Text] [Related]
48. Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines.
Ariyama Y; Mori T; Shinomiya T; Sakabe T; Fukuda Y; Kanamaru A; Yamada Y; Isobe M; Seto M; Nakamura Y; Inazawa J
J Hum Genet; 1999; 44(6):357-63. PubMed ID: 10570904
[TBL] [Abstract][Full Text] [Related]
49. T-cell prolymphocytic leukemia with a novel translocation (6;11)(q21;q23).
Wong KF; Chan JK; Sin VC
Cancer Genet Cytogenet; 1999 Jun; 111(2):149-51. PubMed ID: 10347553
[TBL] [Abstract][Full Text] [Related]
50. Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker.
Stengel A; Kern W; Zenger M; Perglerová K; Schnittger S; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2016 Jan; 55(1):82-94. PubMed ID: 26493028
[TBL] [Abstract][Full Text] [Related]
51. A case of T cell prolymphocytic leukemia involving blast transformation.
Ichikawa K; Noguchi M; Imai H; Sekiguchi Y; Wakabayashi M; Sawada T; Komatsu N
Int J Hematol; 2011 May; 93(5):667-672. PubMed ID: 21505955
[TBL] [Abstract][Full Text] [Related]
52. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.
Thick J; Metcalfe JA; Mak YF; Beatty D; Minegishi M; Dyer MJ; Lucas G; Taylor AM
Oncogene; 1996 Jan; 12(2):379-86. PubMed ID: 8570215
[TBL] [Abstract][Full Text] [Related]
53. Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.
Madani A; Choukroun V; Soulier J; Cacheux V; Claisse JF; Valensi F; Daliphard S; Cazin B; Levy V; Leblond V; Daniel MT; Sigaux F; Stern MH
Blood; 1996 Mar; 87(5):1923-7. PubMed ID: 8634440
[TBL] [Abstract][Full Text] [Related]
54. SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
Johansson P; Klein-Hitpass L; Choidas A; Habenberger P; Mahboubi B; Kim B; Bergmann A; Scholtysik R; Brauser M; Lollies A; Siebert R; Zenz T; Dührsen U; Küppers R; Dürig J
Blood Cancer J; 2018 Jan; 8(1):11. PubMed ID: 29352181
[TBL] [Abstract][Full Text] [Related]
55. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy.
Sakhdari A; Tang G; Ginsberg LE; Hirsch-Ginsberg CF; Bueso-Ramos CE; Medeiros LJ; Miranda RN
Case Rep Pathol; 2019; 2019():4915086. PubMed ID: 30941227
[TBL] [Abstract][Full Text] [Related]
56. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.
Yamasaki S; Nitta H; Kondo E; Uchida N; Miyazaki T; Ishiyama K; Kiyota M; Matsuoka H; Ichinohe T; Fukuda T; Atsuta Y; Suzumiya J; Suzuki R
Ann Hematol; 2019 Sep; 98(9):2213-2220. PubMed ID: 31327025
[TBL] [Abstract][Full Text] [Related]
57. T-cell prolymphocytic leukemia.
Dearden CE
Med Oncol; 2006; 23(1):17-22. PubMed ID: 16645226
[TBL] [Abstract][Full Text] [Related]
58. Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy.
Nowak D; Le Toriellec E; Stern MH; Kawamata N; Akagi T; Dyer MJ; Hofmann WK; Ogawa S; Koeffler HP
Haematologica; 2009 Apr; 94(4):518-27. PubMed ID: 19278963
[TBL] [Abstract][Full Text] [Related]
59. T-cell Prolymphocytic Leukemia.
Matutes E
Cancer Control; 1998 Jan; 5(1):19-24. PubMed ID: 10761013
[TBL] [Abstract][Full Text] [Related]
60. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
